These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26967561)

  • 1. Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.
    Mori F; Ferraiuolo M; Santoro R; Sacconi A; Goeman F; Pallocca M; Pulito C; Korita E; Fanciulli M; Muti P; Blandino G; Strano S
    Oncotarget; 2016 Apr; 7(15):20532-48. PubMed ID: 26967561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
    Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
    Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA ZFAS1 interacts with miR-150-5p to regulate Sp1 expression and ovarian cancer cell malignancy.
    Xia B; Hou Y; Chen H; Yang S; Liu T; Lin M; Lou G
    Oncotarget; 2017 Mar; 8(12):19534-19546. PubMed ID: 28099946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression.
    Li J; Chen Y; Zhao J; Kong F; Zhang Y
    Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1.
    Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
    Oncotarget; 2017 Mar; 8(13):22003-22013. PubMed ID: 28423543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-suppressing roles of miR-214 and miR-218 in breast cancer.
    Liu B; Tian Y; Li F; Zhao Z; Jiang X; Zhai C; Han X; Zhang L
    Oncol Rep; 2016 Jun; 35(6):3178-84. PubMed ID: 27109339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
    Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-488 acts as a tumor suppressor gene in gastric cancer.
    Zhao Y; Lu G; Ke X; Lu X; Wang X; Li H; Ren M; He S
    Tumour Biol; 2016 Jul; 37(7):8691-8. PubMed ID: 26738864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
    Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin.
    Pogribny IP; Filkowski JN; Tryndyak VP; Golubov A; Shpyleva SI; Kovalchuk O
    Int J Cancer; 2010 Oct; 127(8):1785-94. PubMed ID: 20099276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct targeting of HGF by miR-16 regulates proliferation and migration in gastric cancer.
    Li S; Zhang H; Wang X; Qu Y; Duan J; Liu R; Deng T; Ning T; Zhang L; Bai M; Zhou L; Wang X; Ge S; Ying G; Ba Y
    Tumour Biol; 2016 Nov; 37(11):15175-15183. PubMed ID: 27683052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
    Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
    Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
    Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
    Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.
    Suliman MA; Zhang Z; Na H; Ribeiro AL; Zhang Y; Niang B; Hamid AS; Zhang H; Xu L; Zuo Y
    Int J Mol Med; 2016 Sep; 38(3):776-84. PubMed ID: 27460529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.
    Al-Haidari AA; Syk I; Thorlacius H
    Oncotarget; 2017 Feb; 8(9):14887-14896. PubMed ID: 28146427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.